Synairgen (SNG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

161.00p
   
  • Change Today:
    -1.30p
  • 52 Week High: 224.66p
  • 52 Week Low: 77.00p
  • Currency: UK Pounds
  • Shares Issued: 201.34m
  • Volume: 607,091
  • Market Cap: £324.16m
  • RiskGrade: 510

Latest ShareCast News

Synairgen drug proves effective against Covid variants in lab tests

By Abigail Townsend

Date: Monday 24 May 2021

(Sharecast News) - A drug being developed by Synairgen to treat severe lung infections has shown promising laboratory results against emerging variants of Covid-19, the biotech announced on Monday.

Synairgen Regulatory News

Synairgen Notice of Interim Results 21-Sep-2021 07:00 RNS
Holding(s) in Company 10-Sep-2021 11:30 RNS
Exercise of Options and Total Voting Rights 12-Aug-2021 16:12 RNS
Holding(s) in Company 06-Aug-2021 12:21 RNS
Holding(s) in Company 29-Jun-2021 16:28 RNS

Synairgen News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Synairgen Market Data

Currency UK Pounds
Share Price 161.00p
Change Today -1.30p
% Change -0.80 %
52 Week High 224.66p
52 Week Low 77.00p
Volume 607,091
Shares Issued 201.34m
Market Cap £324.16m
RiskGrade 510

Synairgen Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.64% above the market average48.64% above the market average48.64% above the market average48.64% above the market average48.64% above the market average
92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average
Price Trend
0.84% below the market average0.84% below the market average0.84% below the market average0.84% below the market average0.84% below the market average
19.35% above the sector average19.35% above the sector average19.35% above the sector average19.35% above the sector average19.35% above the sector average
Income
5.46% above the market average5.46% above the market average5.46% above the market average5.46% above the market average5.46% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Synairgen Dividends

No dividends found

Trades for 23-Sep-2021

Time Volume / Share Price
16:12 2,467 @ 161.60p
16:11 445 @ 161.00p
16:04 611 @ 161.68p
16:00 2,500 @ 161.27p
15:59 304 @ 161.10p

Synairgen Key Personnel

CEO Richard J Marsden
Finance Director John C Ward

Top of Page